Thirty-one members of the University of Chicago faculty have received distinguished service professorships or named ...
Contineum Therapeutics, Inc. (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology ...
Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases, ...
(GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) ("atai” or "Company”), a clinical-stage biopharmaceutical company ...
VANCOUVER, British Columbia, Dec. 31, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB ... of AI,” and participated in a panel discussion on the fusion of AI and Neuroscience with fellow AI ...
Public universities like UMass are subject to the FOIA because they receive federal funding. Karatsoreos said the University ...
VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES' or the "Company"), a cognitive computing company specializing in next generation intelligent ...
FOBI AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) ("Fobi" or the "Company") announces that it has applied to its principal regulator ... Now, a new perspective piece published today Nature Neuroscience ...
Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications: San Diego Thursday, January 9, 2025, 14:00 ...
Geode Capital Management LLC grew its holdings in shares of Alto Neuroscience, Inc. (NYSE:ANRO – Free Report) by 148.7% in the 3rd quarter, HoldingsChannel.com reports.The firm owned 469,988 ...
Alto Neuroscience, Inc. (ANRO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...
abrdn plc purchased a new stake in shares of Vigil Neuroscience in the third quarter valued at $799,000. Ensign Peak Advisors Inc boosted its position in shares of Vigil Neuroscience by 72.8% in ...